Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D M Angaran

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
American Journal of Hospital Pharmacy|September 1, 1991
Selecting, developing, and evaluating indicatorsD M Angaran
American Journal of Pharmaceutical Education|November 9, 1975
A response to Dr. Knapp's presentation: "Coordinating and Optimizing Educational Efforts between Basic Science Faculty and Clinical Faculty: Pharmacy Administration"D M Angaran
American Journal of Hospital Pharmacy|September 1, 1991
Quality assurance to quality improvement: measuring and monitoring pharmaceutical careD M Angaran
Employee Benefits Journal|June 1, 1997
Retiree health care: a new model for improving health and reducing costsW G Erwin, D M Angaran
Drug Intelligence & Clinical Pharmacy|July 11, 1978
Johnny can't readL P Bast, D M Angaran
American Journal of Hospital Pharmacy|September 1, 1978
Cephalosporin-clinitest interaction: comparison of cephalothin, cefazolin and cephradineM E MacCara, D M Angaran
Drug Intelligence & Clinical Pharmacy|March 1, 1984
Colloids vs. crystalloids--a continuing controversyA D Ross, D M Angaran
Critical Care Medicine|May 1, 1992
Evolving role of the pharmacist in critical careJ F Dasta, D M Angaran
Annals of Internal Medicine|September 1, 1983
Volume of infusion controller and delayed vasopressor effectA D Spigelman, D M Angaran
Pharmaceutical Research|January 1, 1991
The effects of hemodilution, pH, and protamine on lidocaine plasma protein binding and red blood-cell uptake in vitroR P Remmel, A K Copa, D M Angaran
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
American Journal of Hospital Pharmacy|September 1, 1991
Selecting, developing, and evaluating indicatorsD M Angaran
American Journal of Pharmaceutical Education|November 9, 1975
A response to Dr. Knapp's presentation: "Coordinating and Optimizing Educational Efforts between Basic Science Faculty and Clinical Faculty: Pharmacy Administration"D M Angaran
American Journal of Hospital Pharmacy|September 1, 1991
Quality assurance to quality improvement: measuring and monitoring pharmaceutical careD M Angaran
Employee Benefits Journal|June 1, 1997
Retiree health care: a new model for improving health and reducing costsW G Erwin, D M Angaran
Drug Intelligence & Clinical Pharmacy|July 11, 1978
Johnny can't readL P Bast, D M Angaran
American Journal of Hospital Pharmacy|September 1, 1978
Cephalosporin-clinitest interaction: comparison of cephalothin, cefazolin and cephradineM E MacCara, D M Angaran
Drug Intelligence & Clinical Pharmacy|March 1, 1984
Colloids vs. crystalloids--a continuing controversyA D Ross, D M Angaran
Critical Care Medicine|May 1, 1992
Evolving role of the pharmacist in critical careJ F Dasta, D M Angaran
Annals of Internal Medicine|September 1, 1983
Volume of infusion controller and delayed vasopressor effectA D Spigelman, D M Angaran
Pharmaceutical Research|January 1, 1991
The effects of hemodilution, pH, and protamine on lidocaine plasma protein binding and red blood-cell uptake in vitroR P Remmel, A K Copa, D M Angaran
Pageof 4